Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Tredje AP fonden

Tredje AP fonden trimmed its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 0.5% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 33,912 shares of the medical equipment provider’s stock after selling 170 shares during the period. Tredje AP fonden’s holdings in Zimmer Biomet Holdings were worth $4,362,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ZBH. Parkside Financial Bank & Trust increased its holdings in shares of Zimmer Biomet Holdings by 2.7% during the 1st quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock worth $102,000 after buying an additional 22 shares during the last quarter. Bronfman E.L. Rothschild L.P. increased its holdings in shares of Zimmer Biomet Holdings by 25.3% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after buying an additional 167 shares during the last quarter. Parallel Advisors LLC increased its holdings in shares of Zimmer Biomet Holdings by 20.8% during the 1st quarter. Parallel Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock worth $138,000 after buying an additional 199 shares during the last quarter. IHT Wealth Management LLC increased its holdings in shares of Zimmer Biomet Holdings by 28.4% during the 1st quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock worth $139,000 after buying an additional 256 shares during the last quarter. Finally, Sandy Spring Bank increased its holdings in shares of Zimmer Biomet Holdings by 1.7% during the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after buying an additional 20 shares during the last quarter. Institutional investors and hedge funds own 85.35% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Tredje AP fonden” was posted by BBNS and is the property of of BBNS. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://baseballnewssource.com/markets/zimmer-biomet-holdings-inc-zbh-shares-sold-by-tredje-ap-fonden/1603695.html.

A number of analysts have recently commented on ZBH shares. Zacks Investment Research downgraded Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 8th. Morgan Stanley increased their price target on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the company an “overweight” rating in a report on Monday, July 17th. Oppenheimer Holdings, Inc. set a $137.00 price target on Zimmer Biomet Holdings and gave the company a “buy” rating in a report on Monday, August 14th. Canaccord Genuity reiterated a “buy” rating and issued a $141.00 price target on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Finally, Needham & Company LLC reiterated a “strong-buy” rating and issued a $153.00 price target on shares of Zimmer Biomet Holdings in a report on Wednesday, July 12th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company. Zimmer Biomet Holdings presently has an average rating of “Hold” and a consensus target price of $136.58.

In other news, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $121.74, for a total transaction of $2,067,875.64. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.07% of the stock is currently owned by insiders.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at 114.40 on Friday. The company’s 50-day moving average is $114.50 and its 200 day moving average is $120.75. The firm has a market cap of $23.13 billion, a price-to-earnings ratio of 32.58 and a beta of 1.21. Zimmer Biomet Holdings, Inc. has a 1-year low of $95.63 and a 1-year high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.10 by ($0.02). Zimmer Biomet Holdings had a net margin of 9.12% and a return on equity of 16.70%. The business had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.95 billion. During the same quarter last year, the firm posted $2.02 earnings per share. Zimmer Biomet Holdings’s revenue was up 1.1% on a year-over-year basis. On average, equities research analysts expect that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be given a dividend of $0.24 per share. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 annualized dividend and a dividend yield of 0.84%. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is currently 27.59%.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game


Leave a Reply

 
© 2006-2017 BBNS.